Search

everythinglearnresearchcommunity

for

Search:↓

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Skin cells control immune cell placement, helping the skin respond better to challenges.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

People with chronic hair loss often have lower Vitamin B12 levels.

Epigenetic changes in blood cells may contribute to alopecia areata.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

VSELs may hold the key to longer life through regenerative therapies.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

Damaged hair follicle stem cells may leave the skin to help maintain youthfulness.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.